96-WEEK CARDIAC MAGNETIC RESONANCE (CMR) RESULTS OF TREATMENT WITH MAVACAMTEN FROM THE EXPLORER COHORT OF THE MAVA-LONG-TERM EXTENSION (LTE) STUDY IN PATIENTS (PTS) WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM)

被引：0

作者：

Saberi, Sara ^{[1
]}

Kramer, Christopher M. ^{[1
]}

Oreziak, Artur ^{[1
]}

Masri, Ahmad ^{[1
]}

Villa, Roberto Barriales ^{[1
]}

Abraham, Theodore P. ^{[1
]}

Lakdawala, Neal K. ^{[1
]}

Wang, Andrew ^{[1
]}

Choudhury, Lubna ^{[1
]}

Rader, Florian ^{[1
]}

Hegde, Sheila M. ^{[1
]}

Kwong, Raymond Y. ^{[1
]}

Balaratnam, Ganesh ^{[1
]}

Kurio, Greg ^{[1
]}

Fox, Shawna ^{[1
]}

Olivotto, Iacopo ^{[1
]}

Owens, Anjali Tiku ^{[1
]}

机构：

[1] Bristol Myers Squibb, Princeton, NJ USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1042-11

引用

页码：326 / 326

页数：1

共 8 条

[1] Changes in standard of care (SOC) medication during long-term mavacamten treatment for obstructive hypertrophic cardiomyopathy (HCM): results from the EXPLORER cohort of MAVA-Long-Term Extension (LTE)
Lakdawala, N.
Afshar, K.
Barriales-Villa, R.
Gimeno-Blanes, J.
Michels, M.
Saberi, S.
Wheeler, M. T.
Balaratnam, G.
Shah, A.
Chen, Y. M.
Sehnert, A. J.
Abraham, T. P.
EUROPEAN HEART JOURNAL, 2023, 44
[2] Long-term effects of mavacamten treatment in obstructive hypertrophic cardiomyopathy (HCM): updated cumulative analysis of the EXPLORER cohort of MAVA-long-term extension (LTE) study up to 120 weeks
Garcia-Pavia, P.
Oreziak, A.
Masri, A.
Barriales-Villa, R.
Abraham, T. P.
Owens, A. T.
Lakdawala, N. K.
Saberi, S.
Wang, A.
Wheeler, M. T.
Choudhury, L.
Balaratnam, G.
Fox, S.
Hegde, S. M.
Olivotto, I.
EUROPEAN HEART JOURNAL, 2023, 44
[3] LONG-TERM SAFETY OF MAVACAMTEN IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INTERIM RESULTS OF THE MAVA-LONG TERM EXTENSION (LTE) STUDY
Rader, Florian
Choudhury, Lubna
Saberi, Sara
Fermin, David
Wheeler, Matthew T.
Abraham, Theodore P.
Oreziak, Artur
Garcia-Pavia, Pablo
Zwas, Donna
Sehnert, Amy J.
Balaratnam, Ganesh
Ma, Grace
Olivotto, Iacopo
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 532 - 532
[4] Long-term safety and efficacy of mavacamten in obstructive hypertrophic cardiomyopathy: up to 3.5-year follow-up results of the EXPLORER cohort of MAVA-Long-Term Extension study
Garcia-Pavia, P.
Oreziak, A.
Masri, A.
Barriales-Villa, R.
Abraham, T. P.
Owens, A. T.
Jensen, M.
Wojakowski, W.
Seidler, T.
Hagege, A.
Balaratnam, G.
Shah, A.
Fox, S.
Hegde, S. M.
Olivotto, I
EUROPEAN HEART JOURNAL, 2024, 45
[5] Long-Term Efficacy and Safety of Mavacamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Interim Results from the MAVERICK-LTE Cohort of the MAVA-LTE Study
Owens, Anjali
Sherrid, Mark V.
Wong, Timothy C.
Bach, Richard G.
Wever-Pinzon, Omar
Rigolli, Marzia
Balaratnam, Ganesh
Ma, Grace
Mealiffe, Matthew E.
Edelberg, Jay M.
CIRCULATION, 2021, 144
[6] LONG-TERM SAFETY AND EFFICACY OF MAVACAMTEN IN PATIENTS (PTS) WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM): UPDATED RESULTS FROM THE PIONEER-OLE STUDY
Masri, Ahmad
Lester, Steven J.
Stendahl, John
Hegde, Sheila M.
Sehnert, Amy
Balaratnam, Ganesh
Fox, Shawna
Wang, Andrew
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 346 - 346
[7] Long-term safety and effectiveness of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) patients (pts): update from PIONEER open-label extension (PIONEER-OLE) study
Wang, A.
Heitner, S. B.
Jacoby, D.
Lester, S.
Fang, L.
Balaratnam, G.
Sehnert, A. J.
EUROPEAN HEART JOURNAL, 2019, 40 : 65 - 65
[8] EFFICACY OF FILGOTINIB (FIL) IN PATIENTS (PTS) WITH RHEUMATOID ARTHRITIS (RA): WEEK (W) 156 RESULTS FROM A LONG-TERM EXTENSION (LTE) STUDY
Buch, M. H.
Aletaha, D.
Caporali, R.
Combe, B.
Schulze-Koops, H.
Gottenberg, J. E.
Tanaka, Y.
Blanco, R.
Takeuchi, T.
Omoruyi, E. V. Ekoka
Van Beneden, K.
Rajendran, V.
Watson, C.
De Leonardis, F.
Emery, P.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 729 - 730

← 1 →